A clinical trial to study the effects of two drugs, eberconazole and sertaconazole in patients with localized fungal infectio
Phase 4
Completed
- Conditions
- Health Condition 1: null- localised tinea infectionsHealth Condition 2: L088- Other specified local infections of the skin and subcutaneous tissue
- Registration Number
- CTRI/2017/08/009435
- Lead Sponsor
- Mahatma Gandhi Medical college Research Institute SriBalajiVidhyapeeth university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 85
Inclusion Criteria
All patients above the 18years, with clinical diagnosis and mycological confirmation (positive KOH test) for tineawill be included in the study
Exclusion Criteria
Patients with tinea of nail
Patients who had received any form of treatment for the same prior to the initiation of the study
Patients with history of hypersensitivity to study drugs
Immunocompromised status
Pregnant or lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in lesion (erythema scaling induration) graded as 0(nil)1(mild)2(moderate)3(severe)Timepoint: Improvement in lesion (erythema scaling induration) graded as 0(nil)1(mild)2(moderate)3(severe) at 2 and 4 weeks
- Secondary Outcome Measures
Name Time Method monitoring adverse eventsTimepoint: throughout study